Xinhuanet reports that a Chinese vaccine against the Hepatitis E Virus (HEV) has entered clinical trial in the United States after two U.S. volunteers were vaccinated on May 1, 2019, according to Xiamen University. In a three-phase process, the Xiamen University will...
Hepatitis E
Category
Xiamen Univ. Research Team-Originated Vaccine Begins Clinical Trials at Emory University USA
Sponsored by the National Institutes of Health (NIH), a Chinese vaccine against the Hepatitis E virus (HEV) has been approved by the U.S. Food and Drug Administration (FDA). Clinical trials will commence in April of 2019. Sold under the trade name Hecolin, it was...